Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCARDIOVASCULAR

Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking

Yuri A. Kuryshev, Eckhard Ficker, Lu Wang, Peter Hawryluk, Adrienne T. Dennis, Barbara A. Wible, Arthur M. Brown, Jiesheng Kang, Xiao-Liang Chen, Kaoru Sawamura, William Reynolds and David Rampe
Journal of Pharmacology and Experimental Therapeutics January 2005, 312 (1) 316-323; DOI: https://doi.org/10.1124/jpet.104.073692
Yuri A. Kuryshev
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eckhard Ficker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hawryluk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne T. Dennis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara A. Wible
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur M. Brown
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiesheng Kang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-Liang Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaoru Sawamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Reynolds
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Rampe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The diamidine pentamidine is used to treat leishmaniasis, trypanosomiasis, and Pneumocystis carinii pneumonia. Treatment may be accompanied by prolongation of the QT interval of the electrocardiogram and torsades de pointes tachycardias. Up to now, it has been thought that therapeutic compounds causing QT prolongation are associated with direct block of the cardiac potassium channel human ether a-go-go-related gene (hERG), which encodes the α subunit of cardiac IKr currents. We show that pentamidine has no acute effects on currents produced by hERG, KvLQT1/mink, Kv4.3, or SCNA5. Cardiac calcium currents and the guinea pig cardiac action potential were also not affected. After overnight exposure, however, pentamidine reduced hERG currents and inhibited trafficking and maturation of hERG with IC50 values of 5 to 8 μM similar to therapeutic concentrations. Surface expression determined in a chemiluminescence assay was reduced on exposure to 10, 30, and 100 μM pentamidine by about 30, 40, and 70%, respectively. These effects were specific for hERG since expression of hKv1.5, KvLQT1/minK, and Kv4.3 was not altered. In isolated guinea pig ventricular myocytes, 10 μM pentamidine prolonged action potential duration APD90 from 374.3 ± 57.1 to 893.9 ± 86.2 ms on overnight incubation. IKr tail current density was reduced from 0.61 ± 0.09 to 0.39 ± 0.04 pA/pF. We conclude that pentamidine prolongs the cardiac action potential by block of hERG trafficking and reduction of the number of functional hERG channels at the cell surface. We propose that pentamidine, like arsenic trioxide, produces QT prolongation and torsades de pointes in patients by inhibition of hERG trafficking.

Footnotes

  • This work was supported by the National Institutes of Health Grants HL71789 and CA106028 (to E.F.) and HL36930 and HL55404 (to A.M.B.).

  • doi:10.1124/jpet.104.073692.

  • ABBREVIATIONS: TdP, torsades de pointes; hERG, human ether a-go-go-related gene; IKr, rapidly activating delayed rectifier K current; ER, endoplasmic reticulum; HA, hemagglutinin; HEK, human embryonic kidney; APD, action potential duration.

    • Received July 5, 2004.
    • Accepted August 31, 2004.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 312 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 312, Issue 1
1 Jan 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCARDIOVASCULAR

Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking

Yuri A. Kuryshev, Eckhard Ficker, Lu Wang, Peter Hawryluk, Adrienne T. Dennis, Barbara A. Wible, Arthur M. Brown, Jiesheng Kang, Xiao-Liang Chen, Kaoru Sawamura, William Reynolds and David Rampe
Journal of Pharmacology and Experimental Therapeutics January 1, 2005, 312 (1) 316-323; DOI: https://doi.org/10.1124/jpet.104.073692

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCARDIOVASCULAR

Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking

Yuri A. Kuryshev, Eckhard Ficker, Lu Wang, Peter Hawryluk, Adrienne T. Dennis, Barbara A. Wible, Arthur M. Brown, Jiesheng Kang, Xiao-Liang Chen, Kaoru Sawamura, William Reynolds and David Rampe
Journal of Pharmacology and Experimental Therapeutics January 1, 2005, 312 (1) 316-323; DOI: https://doi.org/10.1124/jpet.104.073692
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Compression no-reflow in intestinal ischemia-reperfusion
  • Rapid Characterization of Cantú Syndrome Mutations
  • Vericiguat: Nonclinical Cardiovascular Assessment
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics